Xun Li

2.2k total citations
67 papers, 1.8k citations indexed

About

Xun Li is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Xun Li has authored 67 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 35 papers in Oncology and 24 papers in Organic Chemistry. Recurrent topics in Xun Li's work include Cancer therapeutics and mechanisms (13 papers), Synthesis and Biological Evaluation (13 papers) and Peptidase Inhibition and Analysis (10 papers). Xun Li is often cited by papers focused on Cancer therapeutics and mechanisms (13 papers), Synthesis and Biological Evaluation (13 papers) and Peptidase Inhibition and Analysis (10 papers). Xun Li collaborates with scholars based in China, United States and Japan. Xun Li's co-authors include Zbigniew Darżynkiewicz, Jifeng Wu, Frank Traganos, Leilei Shi, Wen‐Kui Dong, Myron R. Melamed, Wenfang Xu, Yuemao Shen, Huaiyu Zhou and Hua Zhou and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Xun Li

67 papers receiving 1.7k citations

Peers

Countries citing papers authored by Xun Li

Since Specialization

Citations

This map shows the geographic impact of Xun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xun Li more than expected).

Fields of papers citing papers by Xun Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xun Li. The network helps show where Xun Li may publish in the future.

Co-authorship network of co-authors of Xun Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xun Li. A scholar is included among the top collaborators of Xun Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xun Li. Xun Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Elevated expression of WSB2 degrades p53 and activates the IGFBP3-AKT-mTOR-dependent pathway to drive hepatocellular carcinoma 2024 ·Experimental & Molecular Medicine ·Xun Li, Chengcheng Zhang, Xiaotong Lin, Jie Zhang, Yujun Zhang, Hongqiang Yu, Zeyu Liu, Yi Gong, (unknown), Chuan‐Ming Xie	11
2	Exploring the structural diversities of three Co(II) complexes constructed from a new quinoline-containing N3O-cavity half-salamo type ligand and various counteranions 2023 ·Polyhedron ·Li-Li Man, Yi-Fan Ding, Xun Li, Li Tong, Wen‐Kui Dong	26
3	Novel Triazolopyridine-Based BRD4 Inhibitors as Potent HIV-1 Latency Reversing Agents 2023 ·ACS Medicinal Chemistry Letters ·(unknown), Xusheng Huang, Hao Sun, (unknown), (unknown), Wei Hu, Zhiyu Li, Zhong Li, Rong‐Hua Luo, Ren‐Rong Tian, (unknown), Liu‐Meng Yang, Yong‐Tang Zheng, Xun Li	1
4	Synthesis and biological evaluation of thieno[3,2- c ]pyrazol-3-amine derivatives as potent glycogen synthase kinase 3β inhibitors for Alzheimer’s disease 2022 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Ning Yan, (unknown), (unknown), Defeng Wang, Xun Li, Chao Liu, Zhaopeng Liu	14
5	Structural optimizations and bioevaluation of N-substituted acridone derivatives as strong topoisomerase II inhibitors 2021 ·Bioorganic Chemistry ·Zhiying Li, (unknown), (unknown), Xun Li	5
6	Design, synthesis, bioevaluation of LFC- and PA-tethered anthraquinone analogues of mitoxantrone 2020 ·Bioorganic Chemistry ·(unknown), Zhaopeng Liu, Xun Li	10
7	Structure-activity relationship of novel acridone derivatives as antiproliferative agents 2020 ·Bioorganic & Medicinal Chemistry ·Jining Chen, Xingkang Wu, Chunhua Lu, Xun Li	3
8	Novel C7-Substituted Coumarins as Selective Monoamine Oxidase Inhibitors: Discovery, Synthesis and Theoretical Simulation 2019 ·Molecules ·Dong Wang, (unknown), Mengyao Guo, Yi Liu, (unknown), Xun Li, Kong De	10
9	Caveolin-1 Plays an Important Role in the Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells into Cardiomyocytes 2016 ·Cardiology ·Ying Chen, Chunxia Wang, Qiang Huang, Dan Wu, Jianing Cao, Xin Xu, Chengjian Yang, Xun Li	11
10	Sequence Variation in Superoxide Dismutase Gene of <i>Toxoplasma gondii</i> among Various Isolates from Different Hosts and Geographical Regions 2015 ·Korean Journal of Parasitology ·Shuai Wang, Aiping Cao, Xun Li, Qunli Zhao, Yuan Liu, Hua Cong, Shenyi He, Huaiyu Zhou	2
11	From French Paradox to Cancer Treatment: Anti-cancer Activities and Mechanisms of Resveratrol 2014 ·Anti-Cancer Agents in Medicinal Chemistry ·Xuan Yang, Xun Li, Jinyu Ren	54
12	Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors 2013 ·Bioorganic & Medicinal Chemistry ·Leilei Shi, Qiang Wang, Haina Wang, Hua Zhou, Yonggang Li, Xun Li	9
13	Design, Synthesis, and Preliminary Activity Evaluation of Novel Peptidomimetics as Aminopeptidase N/CD13 Inhibitors 2011 ·Archiv der Pharmazie ·Xun Li, Junli Wang, Lei Zhang, Wenfang Xu	9
14	Novel matrix metalloproteinase inhibitors derived from quinoxalinone scaffold (Part I) 2010 ·Bioorganic & Medicinal Chemistry ·Yonggang Li, Jian Zhang, Wenfang Xu, Huawei Zhu, Xun Li	23
15	Modulation of P-glycoprotein activity by the substituted quinoxalinone compound QA3 in adriamycin-resistant K562/A02 cells 2010 ·Pharmacological Reports ·Lirui Sun, Julia Li Zhong, Shu‐Xiang Cui, Xun Li, Stephen G. Ward, Yan‐Qiu Shi, Xiao-Fan Zhang, Yanna Cheng, Jianjun Gao, Xian‐Jun Qu	5
16	Novel aminopeptidase N inhibitors derived from antineoplaston AS2–5 (Part II) 2009 ·Bioorganic & Medicinal Chemistry ·Xun Li, (unknown), Jifeng Wu, Yonggang Li, Qiang Wang, Wenfang Xu	15
17	Novel aminopeptidase N inhibitors derived from antineoplaston AS2–5 (Part I) 2009 ·Bioorganic & Medicinal Chemistry ·Xun Li, Junli Wang, Jinpei Li, Jifeng Wu, Yonggang Li, Huawei Zhu, Ruifang Fan, Wenfang Xu	12
18	Design, synthesis, and evaluation of novel galloyl pyrrolidine derivatives as potential anti-tumor agents 2005 ·Bioorganic & Medicinal Chemistry ·Xun Li, (unknown), Wenfang Xu	45
19	An Efficient Approach to 6, 7-Disubstituted-1H-quinoxalin-2-ones 2004 ·Chinese Chemical Letters ·Xun Li, Q. P. Hu, (unknown), Donghua Wang	3
20	Apoptotic Cell Death During Treatment of Leukemias 1994 ·Leukemia & lymphoma ·Xun Li, Jianping Gong, Eric J. Feldman, Karen Seiter, Frank Traganos, Zbigniew Darżynkiewicz	76

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact